Related references
Note: Only part of the references are listed.Truncating Mutations in LRP4 Lead to a Prenatal Lethal Form of Cenani-Lenz Syndrome
Amanda S. Lindy et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
Ming-Kang Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Severe Cenani-Lenz Syndrome Caused by Loss of LRP4 Function
Ariana Kariminejad et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling
Youngwook Ahn et al.
DEVELOPMENT (2013)
Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner
Nicole M. Collette et al.
DEVELOPMENTAL BIOLOGY (2013)
Cenani-Lenz syndrome restricted to limb and kidney anomalies associated with a novel LRP4 missense mutation
Tahir Naeem Khan et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors
Gill Holdsworth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses
Norihiro Yumoto et al.
NATURE (2012)
Distinct Roles of Muscle and Motoneuron LRP4 in Neuromuscular Junction Formation
Haitao Wu et al.
NEURON (2012)
LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways
Jitender Kumar et al.
BONE (2011)
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Olivier Leupin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
Hong Y. Choi et al.
PLOS ONE (2009)
Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK
Natalie Kim et al.
CELL (2008)
Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling
Wendy Balemans et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction
Scott D. Weatherbee et al.
DEVELOPMENT (2006)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
GG Loots et al.
GENOME RESEARCH (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis
TF Day et al.
DEVELOPMENTAL CELL (2005)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
High bone density due to a mutation in LDL-receptor-related protein 5
LM Boyden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
W Balemans et al.
JOURNAL OF MEDICAL GENETICS (2002)
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
RD Little et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
YQ Gong et al.
CELL (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation
G Zhao et al.
ENDOCRINOLOGY (2000)
Share Paper
